Our latest news

We are proud to be leading the way in providing more patient-centric solutions for people with liver disease that helps them and their physician make informed decisions about their care.

Read our latest news to find out more about how we are helping to improve the understanding of liver disease.

Press Release | Data Released at The Liver Meeting® 2018 Shows MRCP+ is a Promising Non-Invasive Technology for Quantitative Evaluation of Hepatobiliary Diseases Posted: November 12, 2018

Liver Disease liverhealth PSC MRCP+ AASLD

Press Release | Predicting Clinical Outcomes with Multiparametric MRI Featuring Liver cT1 Equal to Biopsy, According to Research Presented at The Liver Meeting® 2018 Posted: November 9, 2018

Press Release | Liver Physicians Pioneering National Digital Health Strategy with GE Healthcare Posted: November 6, 2018

Press Release | LiverMultiScan™ receives regulatory clearance in Singapore Posted: October 1, 2018

Press release | NASH-FX trial shows excellent reproducibility of cT1 as a non-invasive biomarker of liver health Posted: September 10, 2018

LiverMultiScan receives regulatory clearance for clinical use in Australia Posted: August 14, 2018

LiverMultiScan

[Press Release] Large population imaging study reveals utility of LiverMultiScan’s corrected T1 measure as potential biomarker for liver health in metabolic diseases Posted: July 27, 2018

Liver Disease Biomarker liverhealth NAFLD NASH ClinicalTrials

New paediatric study into LiverMultiScan now recruiting healthy volunteers Posted: July 16, 2018

LiverMultiScan

New paper released from the University of Nottingham on quantitative T1 mapping in liver disease Posted: July 10, 2018

Biomarker T1

1
2
3
4
5
6
7
8
9
10
11
12
13